loading
前日終値:
$13.73
開ける:
$14.01
24時間の取引高:
3,544
Relative Volume:
0.03
時価総額:
$205.02M
収益:
$54,000
当期純損益:
$-210.26M
株価収益率:
-17.85
EPS:
-0.79
ネットキャッシュフロー:
$-159.01M
1週間 パフォーマンス:
+37.06%
1か月 パフォーマンス:
+57.61%
6か月 パフォーマンス:
+21.51%
1年 パフォーマンス:
-54.84%
1日の値動き範囲:
Value
$13.78
$14.01
1週間の範囲:
Value
$10.26
$14.18
52週間の値動き範囲:
Value
$7.65
$34.40

Lyell Immunopharma Inc Stock (LYEL) Company Profile

Name
名前
Lyell Immunopharma Inc
Name
セクター
Healthcare (1166)
Name
電話
650 695-0677
Name
住所
201 HASKINS WAY, SOUTH SAN FRANCISCO
Name
職員
300
Name
Twitter
Name
次回の収益日
2025-03-12
Name
最新のSEC提出書
Name
LYEL's Discussions on Twitter

LYEL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
LYEL
Lyell Immunopharma Inc
13.85 230.82M 54,000 -210.26M -159.01M -0.79
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.82 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
554.00 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.07 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
593.08 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.00 31.54B 3.81B -644.79M -669.77M -6.24

Lyell Immunopharma Inc Stock (LYEL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-30 ダウングレード BofA Securities Buy → Underperform
2024-06-27 ダウングレード H.C. Wainwright Buy → Neutral
2023-08-28 ダウングレード JP Morgan Overweight → Neutral
2022-11-14 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-11-11 ダウングレード Goldman Buy → Neutral
2022-10-17 開始されました H.C. Wainwright Buy
2021-07-12 開始されました BofA Securities Buy
2021-07-12 開始されました Goldman Buy
2021-07-12 開始されました JP Morgan Overweight
2021-07-12 開始されました Morgan Stanley Overweight
すべてを表示

Lyell Immunopharma Inc (LYEL) 最新ニュース

pulisher
07:08 AM

Visual trend scoring systems applied to Lyell Immunopharma Inc.High Conviction Stock Long-Term Summary - Newser

07:08 AM
pulisher
04:57 AM

Buy Signal for Lyell Immunopharma Inc. Stock Key Technical Indicators to WatchAlgorithmic Forecast for Swing Trading Picks - Newser

04:57 AM
pulisher
04:38 AM

Analyzing drawdowns of Lyell Immunopharma Inc. with statistical toolsReliable Setup Screener with Low Risk - Newser

04:38 AM
pulisher
04:38 AM

Published on: 2025-07-29 03:38:25 - Newser

04:38 AM
pulisher
04:01 AM

How to use a screener to detect Lyell Immunopharma Inc. breakoutsAlpha Stock Picks with Chart Confirmation - Newser

04:01 AM
pulisher
Jul 28, 2025

What is the dividend policy of Lyell Immunopharma Inc. stockAchieve rapid portfolio growth with expert guidance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How to use a screener to detect Lyell Immunopharma Inc. breakouts Free Technical Entry Strategy for Beginners - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

What catalysts could drive Lyell Immunopharma Inc. stock higher in 2025Extraordinary profit generation - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How volatile is Lyell Immunopharma Inc. stock compared to the marketInvest confidently with expert support - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Sectors Driving Future Growth for Lyell Immunopharma Inc. StockHigh Potential Safe Trades - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

What makes Lyell Immunopharma Inc. stock price move sharplyElite Investor Club - Newser

Jul 26, 2025
pulisher
Jul 25, 2025

What drives Lyell Immunopharma Inc. stock priceExceptional financial outcomes - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Lyell Immunopharma $100M Deal: Can Buyers Hold the Stock After 20% Surge? - FXLeaders

Jul 25, 2025
pulisher
Jul 25, 2025

Lyell Immunopharma $100M Deal: Can Buyers Extend the Stock After 20% Surge? - FXLeaders

Jul 25, 2025
pulisher
Jul 25, 2025

Lyell Immunopharma (LYEL) Stock Soars Following Private Placement Announcement - FinancialBuzz.com

Jul 25, 2025
pulisher
Jul 25, 2025

Lyell Immunopharma's $100M Private Placement: How Milestone-Driven Capital Raises De-Risk Biotechs and Create Asymmetric Upside - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

What makes Lyell Immunopharma Inc. stock attractive to long term investorsExplosive capital appreciation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Lyell Immunopharma announces up to $100M equity private placement - TipRanks

Jul 25, 2025
pulisher
Jul 25, 2025

Everest Medicines raises $200M; Epirium Bio targets $55M Series B - Endpoints News

Jul 25, 2025
pulisher
Jul 25, 2025

Lyell Immunopharma Taps Investors For $100 Million In New Funding - Finimize

Jul 25, 2025
pulisher
Jul 25, 2025

Is Lyell Immunopharma Inc. a good long term investmentBreakthrough profits - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Lyell Immunopharma secures up to $100 million in private placement By Investing.com - Investing.com South Africa

Jul 25, 2025
pulisher
Jul 25, 2025

Lyell Immunopharma Secures $100 Million in Private Placement - TipRanks

Jul 25, 2025
pulisher
Jul 25, 2025

Why Lyell Immunopharma Inc. stock attracts strong analyst attentionROI Focused Stock Calls - Newser

Jul 25, 2025
pulisher
Jul 25, 2025

Lyell Immunopharma Announces up to $100 Million Equity Private Placement - GlobeNewswire

Jul 25, 2025
pulisher
Jul 25, 2025

Lyell Immunopharma Raises $100M to Advance Breakthrough Cancer Cell Therapy Through Pivotal Trials - Stock Titan

Jul 25, 2025
pulisher
Jul 25, 2025

Is Lyell Immunopharma Inc. stock overhyped or has real potentialOutstanding capital returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Lyell Immunopharma Inc. stockMarket-leading capital gains - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

Positive week for Lyell Immunopharma, Inc. (NASDAQ:LYEL) institutional investors who lost 70% over the past year - simplywall.st

Jul 23, 2025
pulisher
Jul 22, 2025

Lyell Immunopharma Inc. Stock Analysis and ForecastHigh-yield investments - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Lyell Immunopharma's LYL314: A High-Risk, High-Reward Catalyst in the CAR T-Cell Space - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Lyell: 'Hold' Rating Based On Phase 3 LYL314 LBCL Treatment Program Advancement (LYEL) - Seeking Alpha

Jul 22, 2025
pulisher
Jul 20, 2025

Lyell Immunopharma registers 625,000 shares for resale - MSN

Jul 20, 2025

Lyell Immunopharma Inc (LYEL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.45%
$111.39
price down icon 0.98%
biotechnology ONC
$294.51
price up icon 1.04%
大文字化:     |  ボリューム (24 時間):